Drug Database
DE

desogestrel + ethinylestradiol

✓ Approved

Teva Pharmaceutical Industries Ltd. · ESR1 · 小分子

什么是 desogestrel + ethinylestradiol?

desogestrel + ethinylestradiol 是一种小分子,由Teva Pharmaceutical Industries Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

公司Teva Pharmaceutical Industries Ltd.
药物类别小分子
分子靶点ESR1, PGR
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

desogestrel + ethinylestradiol 作用于 2 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
PGRprogesterone receptor (NR3C3, PR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

相关研究文献

PubMedBMC women's health2026-11-19

The effects of different types of hormonal contraception on bone mineral density in women of reproductive age: a systematic review and meta-analysis.

Sulaimani Mohammed M, Bamagaus Hattan Y HY, Addas Mohamed A MA, Khoujah Reema M RM et al.

Approximately 150 million women worldwide use hormonal contraceptives; however, formulation-specific effects on bone mineral density (BMD) during the reproductive years remain poorly characterized. Prior meta-analyses are limited by the absence of untreated control groups and inadequate heterogeneity quantification, leaving clinicians without reliable guidance. To determine the effect of hormonal contraceptives on lumbar spine and femoral neck bone mineral density (BMD) in reproductive-aged women relative to untreated non-user controls stratified by contraceptive category, progestin class, and ethinylestradiol (EE) dose. This was a pre-registered systematic review and meta-analysis (PROSPERO: CRD420250640432; PRISMA, 2020). The MEDLINE, Embase, Web of Science, and Cochrane CENTRAL of Controlled Trials databases were searched from inception to December 2024. Eligible studies required a mandatory untreated control arm and ≥ 12-month DXA follow-up in women of reproductive age. Effect sizes were pooled as weighted mean differences (WMD) using the DerSimonian-Laird random-effects model. Evidence certainly was rated using GRADE. Seven studies (k = 15 comparisons; n = 1,488 completers) met all inclusion criteria. The pooled WMD for lumbar spine BMD at 12 months was - 0.003 g/cm² (95% CI: -0.010 to + 0.005; p = 0.470; I² = 38.7%), below DXA precision limits and representing less than 0.3% of mean baseline BMD. COC users showed no significant BMD difference from controls across all progestin classes (WMD = - 0.0004 g/cm²; p = 0.925). A clinically interpretable EE-dose gradient emerged: low-dose formulations (≤ 20 µg; k = 8) showed a small but significant homogeneous reduction (WMD = - 0.011 g/cm²; 95% CI: -0.016 to - 0.005; p < 0.001; I² = 0%), while standard-dose formulations (30-35 µg) did not (WMD = + 0.009 g/cm²; p = 0.193). DMPA demonstrated a significant 2.0% lumbar spine BMD reduction (WMD = - 0.020 g/cm²; 95% CI: -0.038 to - 0.002; p = 0.030). RCT-only sensitivity analysis (k = 10) yielded WMD = - 0.006 g/cm² (p = 0.002; I² = 0%). The GRADE certainty was moderate. COCs do not materially alter BMD over 12 months in reproductive-age women, with consistent null effects across all progestin classes. A biologically plausible EE dose gradient was identified; DMPA use warrants individualized counselling given clinically relevant, though reversible, bone loss. Adequately powered long-term randomized trials targeting low-dose formulations, adolescents, and DMPA continuers are urgently needed.

PMID 43052958
阅读全文 →
PubMedAJE advances : research in epidemiology2026-11-19

Development and validation of a 3-item Transportation Security Index for social risk screening assessments and research into the many pathways through which transportation impacts health.

Murphy Alexandra K AK, Griffin Jamie J, Gould-Werth Alix A

Clinicians and researchers studying transportation as a social determinant of health need measurement tools that screen for people with transportation problems and reveal the pathways through which transportation impacts health. Existing versions of the Transportation Security Index (TSI), a validated measure of transportation insecurity, are lengthy, making their use in research and clinical settings difficult. In this paper, we identify and validate an abbreviated 3-item TSI. We derive the TSI-3 from its 6-item counterpart (TSI-6) by analyzing 2022 survey data representative of the US population aged 25 years and older and content expert feedback. To validate the TSI-3, we embedded a split-ballot experiment in a 2024 survey with a similar sampling frame. We compared the TSI-3 and TSI-6's psychometric properties, ability to distinguish between transportation secure and insecure people, prevalence estimates, and associations with self-rated health and major depression. Results demonstrate that the TSI-3 is an effective substitute for the TSI-6 and is faster to administer by 56%. However, whereas the TSI-6 identifies 3 categories of transportation insecurity, the TSI-3 identifies 2. For those seeking a dichotomous measure of transportation insecurity for social risk screening and research purposes, the TSI-3 is an efficient and cost-effective measure.

PMID 43053811
阅读全文 →
PubMedJournal of experimental & clinical cancer research : CR2026-11-19

Mapping the NFYA 3'UTR landscape identifies alternative polyadenylation as a targetable vulnerability in prostate cancer.

Pagani Giulia G, Casirati Chiara C, Pandini Cecilia C, Fornezza Stefania S et al.

Alternative polyadenylation (APA) is increasingly recognized as a pervasive oncogenic mechanism that reshapes post-transcriptional gene regulation and promotes tumor aggressiveness. Whether APA contributes to the dysregulation of NFYA-encoding the regulatory subunit of the oncogenic transcription factor NF-Y-in prostate cancer (PCa) remains largely uncharacterized. We interrogated bulk, single cell and 3'-end RNA-sequencing data from PCa cell lines and patient samples to re-annotate and quantify the usage of NFYA 3'UTRs. The functional consequences of APA were assessed using reporter assays. NFYA APA was experimentally reprogrammed using CRISPR/Cas9-mediated deletion and antisense oligonucleotide (ASO)-based masking of polyadenylation signals, followed by in vitro and in vivo phenotypic analyses. Four functional NFYA 3'UTR isoforms were identified, with one predominantly used across cell lines and tissues. PCa displayed pervasive NFYA 3'UTR shortening, which correlated with tumor grade and metastatic disease, increased NF-YA protein abundance, and enhanced proliferation. 3'UTR lengthening was instead observed upon induction of cellular quiescence or after Enzalutamide treatment. Mechanistically, 3'UTR lengthening reduced NF-YA protein expression through decreased mRNA stability, impaired translation, and enhanced nuclear retention, rather than increased miRNA-mediated repression. Enforced NFYA 3'UTR lengthening in PCa cells via CRISPR/Cas9 or ASOs diminished NF-YA protein levels and suppressed aggressive tumor traits both in vitro and in vivo. These findings establish NFYA APA as a critical determinant of NF-YA oncogenic output and downstream tumor-promoting programs, and as a previously unrecognized driver of PCa progression. Importantly, they provide proof-of-concept for gene-specific, APA-directed therapeutic strategies. ASO-mediated modulation of polyadenylation indeed emerges as a clinically translatable approach to fine-tune oncogene expression, thus opening new avenues for RNA-based precision interventions in aggressive PCa.

PMID 43053175
阅读全文 →
PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Prognostic impact of new-onset left bundle branch block after transcatheter aortic valve replacement according to preoperative diastolic dysfunction severity.

Ohmori Takahiro T, Maeda Koichi K, Pak Kyongsun K, Hamada Yusuke Y et al.

The prognostic impact of new-onset left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) remains unclear. We aimed to investigate whether its impact differs according to preoperative diastolic dysfunction (DD) severity. Among 2006 patients who underwent TAVR between January 2016 and December 2021 at eight Japanese centres, 853 were classified as having grade 1-3 DD according to the American Society of Echocardiography guidelines. Patients were stratified into grade 1 DD (n = 348, 40.8%) and grade 2-3 DD cohorts (n = 505, 59.2%). The primary endpoint was 3-year all-cause death or rehospitalization for heart failure or arrhythmia. Follow-up completeness at 3 years was 78.8% (672/853). Median age was 84 years (interquartile range, 81-87), and 511 patients (59.9%) were female. New-onset LBBB was observed in 146 patients (17.1%) and was associated with the primary endpoint (adjusted hazard ratio [aHR], 1.54; 95% confidence interval [CI], 1.10-2.17; P = .012). In the grade 2-3 DD cohort, new-onset LBBB was associated with the primary endpoint (aHR, 1.99; 95% CI, 1.35-2.94; P = .001), whereas no association was observed in the grade 1 DD cohort (aHR, 0.87; 95% CI, 0.39-1.96; P = .74). The association differed significantly by DD grade (P for interaction = .028). New-onset LBBB was associated with worse outcomes after TAVR, especially in grade 2-3 DD. DD grading may help identify patients more susceptible to adverse impact of new-onset LBBB.

PMID 43053848
阅读全文 →
PubMedNeurological research2026-11-19

Association of apolipoprotein E gene polymorphism with cognitive function and brain structural burden in elderly patients with intracranial atherosclerotic stenosis.

Pan Libing L, Zheng Guanghui G, Ou Kehui K, Jiang Luting L et al.

To investigate whether apolipoprotein E (ApoE) ε4 carrier status is associated with 3-month cognitive performance and structural brain injury in older patients with intracranial atherosclerotic stenosis (ICAS). This prospective cohort study enrolled 150 patients aged ≥60 years with ICAS (≥50% stenosis on MRA/CTA). ApoE ε4 carriers (n = 21, 14.0%) were compared with noncarriers. Primary outcome was 3-month Montreal Cognitive Assessment (MoCA) score. Secondary cognitive outcome was 3-month Mini-Mental State Examination (MMSE) score. White matter hyperintensity burden defined as Fazekas score ≥2 was primary structural outcome. Multivariable linear and logistic regression models adjusted for age, sex, education, symptomatic ICAS, hypertension, and diabetes. Firth's penalized logistic regression addressed near-complete separation in the Fazekas analysis. . ApoE ε4 carrier status was associated with lower 3-month MoCA (β = -1.887, 95% CI: -3.359 to -0.415, P = 0.013) and MMSE scores (β = -1.931, 95% CI: -3.177 to -0.685, P = 0.003). The structural analysis yielded association with Fazekas score ≥2 (Firth OR = 6.144, 95% CI: 1.331 to 59.563, P = 0.017), although this estimate was imprecise and hypothesis-generating. Additional adjustment for baseline cognitive scores changed the cognitive estimates.   . In older patients with ICAS, ApoE ε4 carriage is associated with poorer 3-month global cognitive performance. Given the modest sample size, few ε4 carriers, short follow-up, and single-center design, larger multicenter studies with longer follow-up are needed to clarify the longitudinal relationship between ApoE ε4 status and cognitive change.

PMID 43053464
阅读全文 →
PubMedJournal of cerebrovascular and endovascular neurosurgery2026-11-19

Prior stroke history and functional outcomes after spontaneous intracerebral hemorrhage: An exploratory propensity score-adjusted analysis.

Ko Kyungmok K, An Hyungmi H, Hong Kyung Sook KS, Nam Taekmin T et al.

We evaluated the association between prior stroke history and 3-month functional outcome after spontaneous intracerebral hemorrhage (sICH). We analyzed 258 patients with sICH (36 with and 222 without prior stroke) in a single-center retrospective cohort; 3-month outcome was available in 218 (28 vs. 190). Propensity scores were estimated from age, sex, admission Glasgow Coma Scale (GCS) score, log hematoma volume, intraventricular hemorrhage, infratentorial hemorrhage, and antithrombotic use. The primary analysis was 1:3 propensity score matching; sensitivity analyses used 1:2 and 1:4 matching, stabilized and truncated inverse probability of treatment weighting (IPTW), and overlap weighting. The primary outcome was a 3-month modified Rankin Scale (mRS) score of 0-2. Before adjustment, patients with prior stroke were older, more severely affected, and less often achieved an mRS of 0-2 (7.1% vs. 32.1%; odds ratio [OR] 0.16, 95% confidence interval [CI] 0.04-0.71, p=0.006). After 1:3 matching, the rates were 8.0% and 11.9%, with no significant association on conditional logistic regression (OR 0.94, 95% CI 0.16-5.37, p=0.941). Overlap weighting likewise showed none (OR 0.45, 95% CI 0.06-3.57, p=0.452), whereas IPTW showed a significant association, although residual covariate imbalance remained for age and admission GCS. The crude association between prior stroke history and poor functional outcome was substantially attenuated after adjustment for measured confounders. Prior stroke history alone should not drive prognostic judgment; acute severity and premorbid functional status should also be considered. These exploratory findings require multicenter validation.

PMID 43053567
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多desogestrel + ethinylestradiol